Domain EYEION.com for sale! This premium domain is available now at Kadomain.com

Psoriasis tied to increased risk for sleep disorders

  • medicalxpress.com language
  • 2025-06-03 03:30 event
  • 2 months ago schedule
Psoriasis tied to increased risk for sleep disorders
Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders, according to a study published online May 13 in JEADV Clinical Practice.

2.294. Gut fungi in very-low-birthweight infants modulate oxygen-induced lung damage, study finds

  • 2 months ago schedule
  • medicalxpress.com language

Extremely preterm newborns who weigh less than 3.3 pounds have immature lungs that often require high levels of ventilation oxygen in the hospital. This contributes to the chronic lung disease bronchopulmonary dysplasia, or BPD, the most common cause of death for these tiny infants. BPD exacts a devastating toll on the immature lung.

2.295. Speech by Dr Hanan Balkhy, WHO Regional Director on the occasion marking Egypt achieving ...

  • 2 months ago schedule
  • emro.who.int language

02 June 2025 Your Excellency, Dr Khaled Abdel Ghaffar, Minister of Health and Population of Egypt, Distinguished officials, Representatives of the Egyptian Vaccine Manufacturers Alliance, Colleagues and Partners, On behalf of the World Health Organization, I extend my warmest congratulations to Egypt for becoming the first country in the Eastern Mediterranean Region to achieve the regional target for hepatitis B control, as set by the Regional Committee Resolution EM/RC56/R.5 (2009). This recognition follows a rigorous review led by the independent Regional Validation Committee (RVC). Based on robust and verifiable data, the RVC concluded that Egypt has indeed met the regional target, supported by the following key indicators: Hepatitis B surface antigen (HBsAg) prevalence among children aged 5 years and older is below 1 per cent; Third-dose hepatitis B vaccine coverage maintained at 90 per cent or higher for over a decade; And birth dose coverage has exceeded 90 per cent for at least five years. These achievements are a testament to your leadership, sustained investment, and steadfast commitment to public health. I commend Your Excellency, the Ministry of Health and Population, and the dedicated teams driving Egypt’s national immunization and hepatitis control programmes. Egypt’s success represents not only a national achievement, but a regional milestone—a powerful example of what is possible when science, policy, and public trust align. Through your strong Expanded Programme on Immunization, you have significantly reduced vaccine-preventable diseases, improved child survival, and strengthened health systems—culminating in the elimination of measles and rubella. WHO stands ready to support you in introducing additional life-saving vaccines to protect against rotavirus, human papillomavirus, Read more...

2.296. Eating healthier can protect aging brain

  • 2 months ago schedule
  • medicalxpress.com language

It's never too late to start eating right as a means of protecting your brain health, a new study says.

2.297. Antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer

  • 2 months ago schedule
  • medicalxpress.com language

The first-in-class antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) demonstrated promising efficacy and high response rates for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), according to data from a Phase I/II study led by researchers from The University of Texas MD Anderson Cancer Center.

2.298. ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations

  • 2 months ago schedule
  • medicalxpress.com language

For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer, the oral proteolysis-targeting chimera ER degrader, vepdegestrant, leads to significantly longer progression-free survival in patients with ESR1 mutations, according to a study published online May 31 in the New England Journal of Medicine. The research was presented to coincide with the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.

2.299. Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

  • 2 months ago schedule
  • medicalxpress.com language

Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A less intensive, reduced chemotherapy treatment approach is currently being evaluated in the CompassHER2 pCR trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN).

2.300. FDA issues highest alert over tomato recall in 3 southern states

  • 2 months ago schedule
  • medicalxpress.com language

Salmonella-tainted tomatoes in three southern states could cause severe illness or even death, the U.S. Food and Drug Administration (FDA) warns.

2.301. Guidelines issued for surgical management of chronic rhinosinusitis in adults

  • 2 months ago schedule
  • medicalxpress.com language

In a new clinical practice guideline issued by the American Academy of Otolaryngology-Head and Neck Surgery Foundation and published online May 27 in Otolaryngology-Head and Neck Surgery, recommendations are presented for the surgical management of chronic rhinosinusitis in adults.

2.302. How relative performance feedback can motivate doctors

  • 2 months ago schedule
  • medicalxpress.com language

When physicians receive relative performance feedback on quality of care, the design of the ranking influences whether it motivates them to improve or has a demotivating effect. The specified quality threshold defining outstanding performance and top ranks may not be set too low, nor must it be too difficult to achieve.

2.303. Psoriasis tied to increased risk for sleep disorders

  • 2 months ago schedule
  • medicalxpress.com language

Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders, according to a study published online May 13 in JEADV Clinical Practice.

2.304. Fighting myeloma with fiber: Plant-based diet offers promise

  • 2 months ago schedule
  • medicalxpress.com language

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk of developing multiple myeloma, the second most common type of blood cancer. The study showed that the diet was not only feasible and well-received but also improved several factors that could potentially delay the progression of precancerous conditions that can lead to multiple myeloma.

2.305. Patients say 'yes..ish' to the use of AI in dentistry

  • 2 months ago schedule
  • medicalxpress.com language

As artificial intelligence (AI) continues to be integrated into health care, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in diagnostics. The verdict? Patients are cautiously optimistic, welcoming the potential benefits of AI but drawing a firm line: humans must stay in charge.

2.306. Is dementia risk shaped by infectious diseases?

  • 2 months ago schedule
  • medicalxpress.com language

It may start with forgetfulness, lapses in memory and confusion.

2.307. Circadian preference is associated with impulsivity in adolescents

  • 2 months ago schedule
  • medicalxpress.com language

A new study to be presented at the SLEEP 2025 annual meeting found that adolescents who prefer to sleep and wake up later ("night owls") reported greater impulsivity than those who prefer to sleep and wake up earlier ("morning larks").

2.308. Brain training game offers new hope for drug-free pain management

  • 2 months ago schedule
  • medicalxpress.com language

A trial of an interactive game that trains people to alter their brain waves has shown promise as a treatment for nerve pain—offering hope for a new generation of drug-free treatments.

2.309. Moderna wins narrower US approval for new COVID vaccine

  • 2 months ago schedule
  • medicalxpress.com language

Moderna Inc. gained U.S. approval for a new COVID vaccine for a narrower group of people, in the latest sign that regulators are restricting access to immunizations under the leadership of Health and Human Services Secretary Robert F. Kennedy Jr.

2.310. Study finds seniors are money savvy—until dementia sets in

  • 2 months ago schedule
  • medicalxpress.com language

Older adults are quite aware of their financial abilities—and these abilities actually improve with age—that is, until dementia sets in, according to new research from Binghamton University, State University of New York.

2.311. Molecular stress in old neurons increases susceptibility to neurodegenerative diseases, study finds

  • 2 months ago schedule
  • medicalxpress.com language

As the global population ages, the risk of developing neurodegenerative diseases such as dementia, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) continues to rise. But the molecular mechanisms behind the deterioration of brain cells have remained elusive.

2.312. A new COVID subvariant spreads rapidly as Trump pivots away from vaccines

  • 2 months ago schedule
  • medicalxpress.com language

A new, highly transmissible COVID subvariant has been detected in California—heightening the risk of a potential summer wave as recent moves by the Trump administration threaten to make vaccines harder to get, and more expensive, for many Americans, some health experts warn.

Cookie Policy

We use cookies and similar technologies to help the site provide a better user experience. By using the website you agree to our Cookie Policy, Terms of Use and Privacy Policy.